MitraClip REPAIR MR Study

Conditions

Diseases of the Cardiovascular System

Volunteers
Health Professionals

What is the purpose of this trial?

The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.

Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Trial with
Abbott Cardiovascular Systems, Inc.
Start Date
11/01/2021
End Date
02/28/2024

For more information about this study, contact:

Sarah McManus

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

John K Forrest, MD, FACC, FSCAI
Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine

Sub-Investigators

Last Updated
11/11/2022
Study HIC
#2000031013

MitraClip REPAIR MR Study

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information